$IBM

IBM cut at Oppenheimer as software bull thesis will take longer to materialize By Investing.com

Oppenheimer downgraded IBM to Perform and removed its $350 price target after IBM pre-announced weaker-than-expected Q2 2026 results ahead of a July 22 earnings call. Oppenheimer said IBM missed revenue and segment estimates, with total revenue projected at $17.2B, up 1% YoY, and software growth at 5% vs a 12% estimate.

Original reporting
Published Jul 15, 2026, 11:56 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$IBM
Bearish
medium confidence
Mentioned
$IBM · $OPY
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$IBMBearishMed
01

Why it matters

The downgrade and target removal reflect a reset in expectations for double-digit software CC growth in 2026-27, with near-term range-bound expectations and risk to infrastructure software vendors from IT budget compression.

02

Market read

Traders may reprice IBM’s near-term earnings expectations and software growth trajectory into the July 22 print after the analyst reset.

03

What to watch

The note attributes misses to timing (deals slipping past quarter-end) and buying shifts tied to memory cost pressures, which may reverse in subsequent quarters if deal flow normalizes.

Relevance 7/10Novelty 7/10Timing: ahead of IBM’s July 22 earnings call, after the pre-announcement and analyst downgrade.

Background

Oppenheimer’s change follows IBM’s negative pre-announcement for Q2 2026 ahead of its July 22 earnings call.

Company-level read

Ticker impact

$IBMBearishMedium confidence
Context

Oppenheimer downgraded IBM to Perform and removed its $350 price target after IBM pre-announced weaker Q2 results across segments.

Expected impact

Near-term downside bias and higher volatility into the July 22 earnings call as expectations reset toward range-bound trading.

Evidence & confidence

The article’s newest concrete facts are the downgrade and removal of the $350 target tied to specific pre-announced misses (software and infrastructure) and a slower bull-thesis timeline.

Market effects

Signals potential near-term budget compression risk for infrastructure software vendors, even as hardware/server and storage beneficiaries are noted.

No specific regional impact described.

No explicit global macro linkage beyond IT spending behavior.

Counterpoint

IBM’s software growth is still positive (software revenue +5% YoY) and some components are improving (Red Hat sequential acceleration), which could limit downside if July 22 results stabilize.

Key entities

  • IBM

    Subject of the downgrade after a negative Q2 pre-announcement and segment-level revenue misses.

  • Oppenheimer

    Downgraded IBM to Perform and removed its $350 price target.

  • Param Singh

    Authored the note citing misses across segments and slower bull-thesis materialization.

Related articles

$ACNMed

Accenture Acquires IBM Stake in UniCredit Tech Venture

Accenture (NYSE: ACN) will buy IBM’s (NYSE: IBM) majority stake in a joint venture with UniCredit to modernize UniCredit’s IT across 13 European markets. UniCredit will keep a minority stake. Accenture will run operations after closing, while IBM will continue as a technology supplier. Deal is subject to regulatory approvals; no financial terms disclosed.

$IBMMedAI 8/10

Critical RCE in IBM Langflow Triggers CISA Emergency Deadline

CISA added a critical IBM Langflow flaw, CVE-2026-9198 (CVSS 9.8), to its KEV catalog on Aug 4, 2026. Under BOD 26-04, US federal agencies must remediate or disconnect affected systems by Aug 7, 2026, and conduct forensic triage. The unauthenticated RCE chains default endpoints to mint a SUPERUSER token and execute arbitrary Python code. Langflow is part of IBM’s watsonx via DataStax acquisition.

$ACNMed

Accenture Takes Over IBM’s Stake In Technology JV With UniCredit

Accenture (ACN) will buy IBM’s controlling stake in a technology joint venture with UniCredit (UCG) that runs major IT operations for the bank, with UniCredit keeping a minority interest. Accenture will take primary operational responsibility after regulatory approvals and employee consultations. IBM will exit equity but continue as a technology supplier, including IBM Z platforms and software.

$IBMMed

IBM’s Quantum Bet Just Got Bigger—What the HRL Deal Means for Investors

IBM (NYSE:IBM) agreed to acquire HRL Laboratories from Boeing (NYSE:BA) and General Motors (NYSE:GM), adding electron spin qubit expertise to its superconducting-qubit roadmap. IBM said it will invest over $10 billion in quantum over five years and cited US government funding of over $2 billion. The article compares IBM’s valuation (forward P/E ~17.5, P/S 3.1) with Alphabet (26.8, 10.3).

$ACNMed

Accenture buys IBM's stake in UniCredit Tech JV

Accenture will acquire IBM’s 51% stake in V-TServices, a tech JV managing UniCredit’s banking infrastructure across 13 European markets, according to Tech Times and company announcements. Accenture becomes co-owner and operating partner to deliver cloud, data, and AI services. IBM will continue supplying IBM Z platforms pending regulatory approvals.